118 related articles for article (PubMed ID: 21178268)
1. Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer.
Kohli M; Rothberg PG; Feng C; Messing E; Joseph J; Rao SS; Hendershot A; Sahsrabudhe D
Cancer Biomark; 2010; 7(2):101-8. PubMed ID: 21178268
[TBL] [Abstract][Full Text] [Related]
2. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.
Nam RK; Zhang WW; Trachtenberg J; Diamandis E; Toi A; Emami M; Ho M; Sweet J; Evans A; Jewett MA; Narod SA
J Clin Oncol; 2003 Jun; 21(12):2312-9. PubMed ID: 12805332
[TBL] [Abstract][Full Text] [Related]
4. Human kallikrein-2 gene polymorphism is associated with the occurrence of prostate cancer.
Chiang CH; Hong CJ; Chang YH; Chang LS; Chen KK
J Urol; 2005 Feb; 173(2):429-32. PubMed ID: 15643194
[TBL] [Abstract][Full Text] [Related]
5. The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
Nam RK; Zhang WW; Jewett MA; Trachtenberg J; Klotz LH; Emami M; Sugar L; Sweet J; Toi A; Narod SA
Clin Cancer Res; 2005 Dec; 11(23):8391-7. PubMed ID: 16322300
[TBL] [Abstract][Full Text] [Related]
6. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
7. Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer.
Reis ST; Viana NI; Leite KR; Diogenes E; Antunes AA; Iscaife A; Nesrallah AJ; Passerotti CC; Srougi V; Pontes-Junior J; Salles ME; Nahas WC; Srougi M
PLoS One; 2016; 11(12):e0166380. PubMed ID: 27906997
[TBL] [Abstract][Full Text] [Related]
8. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P
Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562
[TBL] [Abstract][Full Text] [Related]
9. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility loci associated with prostate cancer progression and mortality.
Gallagher DJ; Vijai J; Cronin AM; Bhatia J; Vickers AJ; Gaudet MM; Fine S; Reuter V; Scher HI; Halldén C; Dutra-Clarke A; Klein RJ; Scardino PT; Eastham JA; Lilja H; Kirchhoff T; Offit K
Clin Cancer Res; 2010 May; 16(10):2819-32. PubMed ID: 20460480
[TBL] [Abstract][Full Text] [Related]
11. The role of single nucleotide polymorphisms of miRNAs 100 and 146a as prognostic factors for prostate cancer.
Camargo JA; Lopes RE; Ferreira GFD; Viana NI; Guimaraes V; Leite KRM; Nahas WC; Srougi M; Antunes AA; Reis ST
Int J Biol Markers; 2021 Jun; 36(2):50-56. PubMed ID: 34030497
[TBL] [Abstract][Full Text] [Related]
12. Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.
Cramer SD; Sun J; Zheng SL; Xu J; Peehl DM
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2451-7. PubMed ID: 18768516
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer.
Chatrabnous N; Ghaderi A; Ariafar A; Razeghinia MS; Nemati M; Jafarzadeh A
Cytokine; 2019 Jan; 113():221-227. PubMed ID: 30057362
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
[TBL] [Abstract][Full Text] [Related]
15. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
[TBL] [Abstract][Full Text] [Related]
16. Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer.
Nasser NJ; Thoms J; Soosaipillai A; Pintilie M; Wang R; Diamandis EP; Bristow RG
Radiother Oncol; 2017 Sep; 124(3):427-432. PubMed ID: 28427756
[TBL] [Abstract][Full Text] [Related]
17. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
[TBL] [Abstract][Full Text] [Related]
18. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.
Perez CA; Chen H; Shyr Y; Courtney R; Zheng W; Cai Q; Hwang M; Jaboin J; Schleicher S; Moretti L; Wills M; Smith JA; Lu B
J Urol; 2010 May; 183(5):2062-9. PubMed ID: 20303520
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.
Williams SA; Xu Y; De Marzo AM; Isaacs JT; Denmeade SR
Prostate; 2010 May; 70(7):788-96. PubMed ID: 20058238
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
